The anandamide transport inhibitor AM404 activates vanilloid receptors
(2000) In European Journal of Pharmacology 396(1). p.39-42- Abstract
The possibility that the anandamide transport inhibitor N-(4-hydroxyphenyl)-5,8,11,14-eicosatetraenamide (AM404), structurally similar to the vanilloid receptor agonists anandamide and capsaicin, may also activate vanilloid receptors and cause vasodilation was examined. AM404 evoked concentration-dependent relaxations in segments of rat isolated hepatic artery contracted with phenylephrine. Relaxations were abolished in preparations pre-treated with capsaicin. The calcitonin-gene related peptide (CGRP) receptor antagonist CGRP-(8-37) also abolished relaxations. The vanilloid receptor antagonist capsazepine inhibited vasodilation by AM404 and blocked AM404-induced currents in patch-clamp experiments on Xenopus oocytes expressing the... (More)
The possibility that the anandamide transport inhibitor N-(4-hydroxyphenyl)-5,8,11,14-eicosatetraenamide (AM404), structurally similar to the vanilloid receptor agonists anandamide and capsaicin, may also activate vanilloid receptors and cause vasodilation was examined. AM404 evoked concentration-dependent relaxations in segments of rat isolated hepatic artery contracted with phenylephrine. Relaxations were abolished in preparations pre-treated with capsaicin. The calcitonin-gene related peptide (CGRP) receptor antagonist CGRP-(8-37) also abolished relaxations. The vanilloid receptor antagonist capsazepine inhibited vasodilation by AM404 and blocked AM404-induced currents in patch-clamp experiments on Xenopus oocytes expressing the vanilloid subtype 1 receptor (VR1). In conclusion, AM404 activates native and cloned vanilloid receptors. Copyright (C) 2000 Elsevier Science B.V.
(Less)
- author
- Zygmunt, Peter M.
LU
; Chuang, Huai Hu
; Movahed, Pouya
; Julius, David
and Högestätt, Edward D.
LU
- organization
- publishing date
- 2000-05-12
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- Afferent, Cannabinoid, Capsaicin, Neuron, Pain, Receptor, Sensory, Vasodilation
- in
- European Journal of Pharmacology
- volume
- 396
- issue
- 1
- pages
- 4 pages
- publisher
- Elsevier
- external identifiers
-
- pmid:10822052
- scopus:0034640192
- ISSN
- 0014-2999
- DOI
- 10.1016/S0014-2999(00)00207-7
- language
- English
- LU publication?
- yes
- id
- dd40c882-13aa-4caa-9142-9cd9b0054f88
- date added to LUP
- 2019-05-31 21:31:52
- date last changed
- 2025-10-16 23:55:44
@article{dd40c882-13aa-4caa-9142-9cd9b0054f88,
abstract = {{<p>The possibility that the anandamide transport inhibitor N-(4-hydroxyphenyl)-5,8,11,14-eicosatetraenamide (AM404), structurally similar to the vanilloid receptor agonists anandamide and capsaicin, may also activate vanilloid receptors and cause vasodilation was examined. AM404 evoked concentration-dependent relaxations in segments of rat isolated hepatic artery contracted with phenylephrine. Relaxations were abolished in preparations pre-treated with capsaicin. The calcitonin-gene related peptide (CGRP) receptor antagonist CGRP-(8-37) also abolished relaxations. The vanilloid receptor antagonist capsazepine inhibited vasodilation by AM404 and blocked AM404-induced currents in patch-clamp experiments on Xenopus oocytes expressing the vanilloid subtype 1 receptor (VR1). In conclusion, AM404 activates native and cloned vanilloid receptors. Copyright (C) 2000 Elsevier Science B.V.</p>}},
author = {{Zygmunt, Peter M. and Chuang, Huai Hu and Movahed, Pouya and Julius, David and Högestätt, Edward D.}},
issn = {{0014-2999}},
keywords = {{Afferent; Cannabinoid; Capsaicin; Neuron; Pain; Receptor; Sensory; Vasodilation}},
language = {{eng}},
month = {{05}},
number = {{1}},
pages = {{39--42}},
publisher = {{Elsevier}},
series = {{European Journal of Pharmacology}},
title = {{The anandamide transport inhibitor AM404 activates vanilloid receptors}},
url = {{http://dx.doi.org/10.1016/S0014-2999(00)00207-7}},
doi = {{10.1016/S0014-2999(00)00207-7}},
volume = {{396}},
year = {{2000}},
}